David M. Rubenstein insider trades

Open-market stock purchases and sales by David M. Rubenstein, Director at Carlyle Group Inc, from SEC Form 4 filings since Jan 1, 2020.

Recent trades

DateStockTradeValue
Sep 11, 2026CG Carlyle Group IncSold (not open market)—
Sep 11, 2026CG Carlyle Group IncSold$17.1M
May 6, 2026MRNA Moderna, IncBought (not open market)—
May 6, 2026MRNA Moderna, IncBought (not open market)—
Apr 30, 2026MRNA Moderna, IncBought (not open market)—
Mar 19, 2026CG Carlyle Group IncSold (not open market)—
Mar 19, 2026CG Carlyle Group IncSold$23.3M
Dec 10, 2025CG Carlyle Group IncSold (not open market)—
Dec 10, 2025CG Carlyle Group IncSold$35.3M

Companies traded

  • CG Carlyle Group Inc: 13 sales, last Sep 11, 2026
  • MRNA Moderna, Inc: other filings, last May 6, 2026

Get free alerts when David M. Rubenstein files a new trade →